Member Info for Burt2000

A fair comment Gerard, and I wasn’t aware that any contract RNS has to be over 10% of revenue to be considered material. Without sounding disrespectful, the customers/clients may not read the RNS’s but shareholders and potential share holders do and you know how the AIM investors are, a lot of SP’s react to news or lack of news . I’m quite content to sit as I’m investing for the long term but a lot of AIM investors don’t have the same outlook. If only we could get out of AIM as this seems to be a recurring theme whenever the SP falls.....all in good time

I think we will be stuck in the mid 20’s until news. An update on phase 3 testing would be good. You know how AIM is, it doesn’t like waiting on news. Probably a bit of uncertainty in the markets with the whole Brexit thing this week. Even though are target markets are outside the UK.

Where is the 100million BT units figure coming from out of interest? I would have thought they will be made (or bought in if that’s what the plan is) in batches as and when contracts are signed? It will probably be small to start off with say a factory wants 1000 units a few thousand chips and a few scanners? Supply those, get paid for them, rinse and repeat as orders come in. Unless there is a big order from government/nhs/ cruise liners etc. It’s all guess work at this stage though.

From 16th November RNS

“As we progress towards commercialisation, PulMoBioMed's patented technology will enable a quick roll-out of our Microtox BT breath test once field trials have completed. We look forward to reporting the results in due course."

Probably awaiting the results of phase 3 field tests and there probably has to be a signed contract before DVRG would put its name to anything as it would be market sensitive. Im content to wait though.

How can DVRG not be involved! Have a look at appendix 7.1 (Innovation and partnerships) the problems they highlighted are exactly what Microtox PD solves! GB has to be all over this like a rash, he’s usually well ahead of the game.

I think everyone expects the BT to fail and this is priced into the SP. if it turns out that it’s more reliable and accurate than the lateral flow tests we are off to the races. I really hope this is the case and we get that magic RNS in the next few weeks. If not we’ll no biggie, as said it’s the water detection and labskin that will be a bigger player, the BT being a success would be the cherry on top.

Trouble buying this morning, had to wait for ages to get another £500 worth. Could bet get the buy at 24p so had to settle for 25p. Ah well as I say anything 25p and under is my buy range

No such thing as bad publicity. As GB says now all his followers know about DVRG and yes thanks for the opportunity to lower my average further, getting into the low 30’s after today’s top up.

I say fair play to GB for putting TW back in his box. I would do the same....it’s an Irish thing ;-)
GB clearly doesn’t suffer fools gladly.

That should give a bit of confidence to anyone who’s having doubts about where DVRG are going in the future.

I think it’s quite simple. Anyone who isn’t happy here should move on, I really don’t know why someone would waste time and energy on something they have no confidence in. I’m all for balanced discussion on the good and the bad (it’s isn’t all rosey here) but the moaning is starting to grind. I also got slightly burnt on the news of the BT spike but I didn’t go in too heavy and my average is on the 30’s(having averaged down) so I’m not sitting on a massive loss.

The only reason I would feel the need to sell up now is if the company was going bust and I highly doubt that will happen, it’s growing rapidly (recruitment of staff, large increases in revenue) and I believe DVRG is only getting traction now so lots more to come in the future. I’ve sold out before in the past when a share is going thorough a bad patch and lived to regret it as it recovers and goes higher after x amount of time. If DVRG was falling off a cliff I would sell now but it ain’t so I’m sitting tight and seeing what next year brings. The SP will react to the growth in good time.

If the current SP gets rid of unhappy traders im fine with that. I invest rather than trade so the SP in a year or 2 time is what I’m concerned about, not today, I’ll accumulate on dips. Anyone after a quick buck won’t get it here I feel, there are plenty of other choices on AIM. Traders make a market as do those who hold long so it’s not a personal dig. It would however be nice If we could get out of this 20-30p trading range we seem stuck in.

keep calm and buy more ;-)

I do agree that big data is going to be a lot more valuable as time goes on, the government are all over it, just listen to the buzz words around covid, we need the data, we have to build up the data, analyse the data etc. Maybe a little naive of me to expect more RNS’s particularly for the likes of the cosmetics companies who want to keep it away from competitors but the like of sales of water monitoring equipment etc does warrant an RNS imo.

Thanks for clearing that up Davde. Regards the 20 PD units to China does that not warrant an RNS? Also I genuinely believe shareholders and potential investors would like to see details of the labskin orders of it had never been announced before.

I gather we are receiving revenue from this and going by yesterday’s presentation it’s recurring. Just a question, have the details of these contracts ever been released in an RNS? Ie how much the contracts are worth and how long they last?
Thanks.

Can the breathalyser be adapted to test for antibodies an immunity associated with the vaccines? I think a BT that can do that may be more in demand as the governments testing regime turns more toward testing if the vaccines have actually worked in the coming months/year. I don’t recall GB saying there is no rush to publish results, maybe I missed it and If it was said I agree it’s not a great thing to say as shareholders are waiting on tenterhooks to see if it’s ready to go ahead and try to get some orders in. Are there companies who have shown a definite interest in placing and order should all of the tests go as planned?

I agree that more RNS’s to the man on the street need. Be released. GB talked about recurring revenue with the top 18 cosmetics companies with labskin, but what are these revenues? Same with Microtox PD revenue, what are the contracts, who with, for how long and how much? This is the kind of stuff that will make people sit up and listen and to me it’s market sensitive so should be announced. Also an idea of how long is left on phase 3 trials would be good ie will we get feedback before Christ or will it be January. AIM investors love RNS’s. Sales and contract details will attract people!

As hard as it is to watch, 25/26p is my top up target so I’ve just bought more(might pay off might not).My average is now in the high 30’s. I think volume is the problem with this share, very few trades today.